Angle PLC | Income Statement

Fiscal year is May-April. All values GBP Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
-
-
361.00
498.00
628.00
Cost of Goods Sold (COGS) incl. D&A
2,211.00
3,784.00
432.00
546.00
959.00
Gross Income
2,211.00
3,784.00
71.00
48.00
331.00
SG&A Expense
-
-
5,318.00
7,337.00
8,551.00
EBIT
-
3,784.00
5,389.00
7,385.00
8,830.00
Unusual Expense
-
94.00
60.00
89.00
103.00
Non Operating Income/Expense
-
-
-
39.00
-
Pretax Income
2,198.00
3,869.00
5,427.00
7,410.00
8,925.00
Income Tax
-
-
309.00
1,018.00
1,387.00
Consolidated Net Income
2,198.00
3,869.00
5,118.00
6,392.00
7,538.00
Net Income
2,025.00
3,576.00
4,924.00
6,567.00
7,556.00
Net Income After Extraordinaries
2,986.00
3,558.00
4,955.00
6,567.00
7,556.00
Net Income Available to Common
1,064.00
3,594.00
4,893.00
6,567.00
7,556.00
EPS (Basic)
0.02
0.08
0.08
0.09
0.08
Basic Shares Outstanding
45,129.80
47,625.00
58,863.70
73,350.50
95,500.80
EPS (Diluted)
0.02
0.08
0.08
0.09
0.08
Diluted Shares Outstanding
45,129.80
47,625.00
58,863.70
73,350.50
95,500.80
EBITDA
2,055.00
3,563.00
5,064.00
6,962.00
8,040.00
Other Operating Expense
-
-
-
-
52.00
Non-Operating Interest Income
13.00
9.00
22.00
25.00
8.00
Minority Interest Expense
173.00
293.00
194.00
175.00
18.00

About Angle

View Profile
Address
The Surrey Research Park
Guildford Surrey GU2 7YD
United Kingdom
Employees -
Website http://angleplc.com
Updated 07/08/2019
ANGLE Plc operates as a holding company, through its subsidiaries engages in providing products in cancer diagnostics and foetal health. Its main product is the Parsortix cell separation system, which can capture very rare cells from blood. The company was founded by Andrew D.